Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

phASCL1-N106 Citations (2)

Originally described in: MicroRNA-mediated conversion of human fibroblasts to neurons.
Yoo AS, Sun AX, Li L, Shcheglovitov A, Portmann T, Li Y, Lee-Messer C, Dolmetsch RE, Tsien RW, Crabtree GR Nature. 2011 Jul 13. doi: 10.1038/nature10323.
PubMed Journal

Articles Citing phASCL1-N106

EGFR mediates activation of RET in lung adenocarcinoma with neuroendocrine differentiation characterized by ASCL1 expression. Bhinge K, Yang L, Terra S, Nasir A, Muppa P, Aubry MC, Yi J, Janaki N, Kovtun IV, Murphy SJ, Halling G, Rahi H, Mansfield A, de Andrade M, Yang P, Vasmatzis G, Peikert T, Kosari F. Oncotarget. 2017 Apr 18;8(16):27155-27165. doi: 10.18632/oncotarget.15676. PubMed
Protein neddylation as a therapeutic target in pulmonary and extrapulmonary small cell carcinomas. Norton JP, Augert A, Eastwood E, Basom R, Rudin CM, MacPherson D. Genes Dev. 2021 Jun;35(11-12):870-887. doi: 10.1101/gad.348316.121. Epub 2021 May 20. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.